8 December 2023 in Journal of the American Chemical Society
Atomically precise Au25 nanoclusters have garnered significant interest in the field of heterogeneous catalysis due to their remarkable activity and selectivity. However, for the extensively studied reaction of low-temperature CO oxidation, their performance has not been competitive compared to other known gold nanocatalysts. To address this, we deposited Au25(SR)18 (R = CH2CH2Ph) nanoclusters onto a manganese oxide support (Au25/MnO2), resulting in a very stable and highly active catalyst. By optimizing the pretreatment temperature, we were able to significantly enhance the performance of the Au25/MnO2 catalyst, which outperformed most other gold catalysts. Impressively, 100% conversion of CO was achieved at temperatures as low as -50 °C, with 50% conversion being reached below -70 °C. Furthermore, the existence of ligands could also influence the negative apparent activation energy observed at intermediate temperatures. Analysis using X-ray photoelectron spectroscopy (XPS), scanning transmission electron microscopy (STEM), and X-ray diffraction (XRD) techniques indicated that the Au25 nanoclusters remained stable on the catalyst surface even after pretreatment at high temperatures. In-situ modulation excitation spectroscopy (MES) spectra also confirmed that the Au cluster was the active site for CO oxidation, highlighting the potential of atomically precise Au25 nanoclusters as primary active sites at very low temperatures.
30 November 2023 in Angewandte Chemie International Edition
17 May 2026 in Energy & Environmental Materials
Ulcerative colitis (UC) is an incurable inflammatory bowel disease characterized by chronic mucosal inflammation, with a continuously increasing global prevalence. Although infrared (IR) therapy has demonstrated anti‐inflammatory potential, conventional devices that can only emit single‐wavelength IR often exhibit limited tissue penetration and poor suboptimal spectral overlap with mammalian absorption. Herein, we develop a broad‐spectrum infrared (BSIR) device enabled with an almost defect‐free graphene based radiator to deliver high output IR aligned with mammalian IR absorption spectra. In a mouse model of UC, BSIR treatment significantly alleviated disease symptoms and promoted mucosal recovery. Crucially, this study shows that BSIR radiation induces the relocation of T lymphocytes to the spleen, leading to reduced immune cell infiltration and inflammation in the colon. Gene expression analysis further reveals enhanced innate immune activity and cell regeneration in colonic tissue. Collectively, these findings demonstrate that BSIR represents a safe, noninvasive therapeutic strategy for UC. More broadly, this study highlights spectrum‐matched IR irradiation as a novel modality for immune modulation, with potential translational relevance for other deep‐tissue inflammatory diseases.